Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events

被引：3
|
作者：
De Luca, Leonardo [1 ,7 ]
Bellettini, Elisa [1 ]
Di Maio, Dario [2 ]
Natale, Enrico [1 ]
Putini, Rita Lucia [1 ]
Anticoli, Sabrina [3 ]
Colivicchi, Furio [4 ]
Calabro, Paolo [2 ]
Musumeci, Francesco [5 ,6 ]
Gabrielli, Domenico [1 ]
机构：
[1] Azienda Osped San Camillo Forlanini, Div Cardiol, Dept Cardiosci, I-00152 Rome, Italy
[2] Univ Campania Luigi Vanvitelli, Div Cardiol, Dept Translat Med, I-81100 Caserta, Italy
[3] Azienda Osped San Camillo Forlanini, Stroke Unit, I-00152 Rome, Italy
[4] S Filippo Neri Hosp, Div Cardiol, I-00135 Rome, Italy
[5] Azienda Osped San Camillo Forlanini, Dept Cardiosci, Cardiac Surg Unit, I-00152 Rome, Italy
[6] Azienda Osped San Camillo Forlanini, Dept Cardiosci, Heart Transplantat Ctr, I-00152 Rome, Italy
[7] Azienda Osped San Camillo Forlanini, Dept Cardiosci, UOC Cardiol, I-00152 Rome, Italy
来源：
JOURNAL OF CLINICAL MEDICINE | 2021年 / 10卷 / 08期
关键词：
antiplatelet therapy; aspirin; clopidogrel; ticagrelor; stroke; TIA; EARLY ASPIRIN USE; RISK PATIENTS; STROKE TRIAL; MINOR STROKE; CLOPIDOGREL; TICAGRELOR; ATTACK; MANAGEMENT;
D O I：
10.3390/jcm10081721
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Stroke is the leading cause of disability and mortality worldwide. After an acute cerebrovascular ischemia, recurrent vascular events, including recurrent stroke or transient ischemic accidents (TIA), occur in around 20% of cases within the first 3 months. In order to minimize this percentage, antiplatelet therapy may play a key role in the management of non-cardioembolic cerebrovascular events. This review will focus on the current evidence of antiplatelet therapies most commonly discussed in practice guidelines and used in clinical practice for the treatment of stroke/TIA complications. The antiplatelet therapies most commonly used and discussed are as follows: aspirin, clopidogrel, and ticagrelor.
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
    Valis, Martin
    Klimova, Blanka
    Novotny, Michal
    Herzig, Roman
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [2] Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
    Tornyos, Daniel
    Balint, Alexandra
    Kupo, Peter
    El Abdallaoui, Oumaima El Alaoui
    Komocsi, Andras
    LIFE-BASEL, 2021, 11 (05):
  • [3] Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
    Krishnan, Kailash
    Law, Zhe Kang
    Minhas, Jatinder S.
    Bath, Philip M.
    Robinson, Thompson G.
    Sprigg, Nikola
    Mavilakandy, Akash
    England, Timothy J.
    Eveson, David
    Mistri, Amit
    Dawson, Jesse
    Appleton, Jason P.
    CLINICAL MEDICINE, 2022, 22 (05) : 449 - 454
  • [4] Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?
    Milionis, Haralampos
    Michel, Patrik
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (21) : 3788 - 3794
  • [5] Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events
    Geoffrey Ling
    Bruce Ovbiagele
    American Journal of Cardiovascular Drugs, 2009, 9 : 197 - 209
  • [6] The use of dual antiplatelet therapy for ischemic cerebrovascular events
    Mele, Francesco
    Gendarini, Claudia
    Pantoni, Leonardo
    NEUROLOGICAL SCIENCES, 2023, 44 (01) : 37 - 43
  • [7] Dual versus single antiplatelet therapy in patients with non-cardioembolic acute ischemic stroke and baseline MRI
    De Marchis, Gian Marco
    Toebak, Anna
    Dittrich, Tolga
    Vlachos, Dimitrios
    Wang, Angela
    Smith, Eric E.
    Mundl, Hardi
    Colorado, Pablo
    Shoamanesh, Ashkan
    Hart, Robert G.
    EUROPEAN STROKE JOURNAL, 2025,
  • [8] Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack An Updated Systematic Review and Meta-Analysis
    Wong, Ka Sing Lawrence
    Wang, Yilong
    Leng, Xinyi
    Mao, Chen
    Tang, Jinling
    Bath, Philip M. W.
    Markus, Hugh S.
    Gorelick, Philip B.
    Liu, Liping
    Lin, Wenhua
    Wang, Yongjun
    CIRCULATION, 2013, 128 (15) : 1656 - 1666
  • [9] A Clinical Update on Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke
    Marsden, Katelyn
    Mak, Hannah Y.
    Crooks, C. Patrick
    Pankaj, Preethy
    Thuhien Nguyen
    Tirschwell, David
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (10)
  • [10] Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack
    De Matteis, Eleonora
    Ornello, Raffaele
    De Santis, Federico
    Foschi, Matteo
    Romoli, Michele
    Tassinari, Tiziana
    Saia, Valentina
    Cenciarelli, Silvia
    Bedetti, Chiara
    Padiglioni, Chiara
    Censori, Bruno
    Puglisi, Valentina
    Vinciguerra, Luisa
    Guarino, Maria
    Barone, Valentina
    Zedde, Marialuisa
    Grisendi, Ilaria
    Diomedi, Marina
    Bagnato, Maria Rosaria
    Petruzzellis, Marco
    Mezzapesa, Domenico Maria
    Di Viesti, Pietro
    Inchingolo, Vincenzo
    Cappellari, Manuel
    Zenorini, Mara
    Candelaresi, Paolo
    Andreone, Vincenzo
    Rinaldi, Giuseppe
    Bavaro, Alessandra
    Cavallini, Anna
    Moraru, Stefan
    Querzani, Pietro
    Terruso, Valeria
    Mannino, Marina
    Pezzini, Alessandro
    Frisullo, Giovanni
    Muscia, Francesco
    Paciaroni, Maurizio
    Mosconi, Maria Giulia
    Zini, Andrea
    Leone, Ruggiero
    Palmieri, Carmela
    Cupini, Letizia Maria
    Marcon, Michela
    Tassi, Rossana
    Sanzaro, Enzo
    Paci, Cristina
    Viticchi, Giovanna
    Orsucci, Daniele
    Falcou, Anne
    EUROPEAN STROKE JOURNAL, 2024, 9 (04) : 989 - 999
12345